<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01180985</url>
  </required_header>
  <id_info>
    <org_study_id>CR-1636BD</org_study_id>
    <nct_id>NCT01180985</nct_id>
  </id_info>
  <brief_title>Dispensing Evaluation of a Galyfilcon A Prototype Lens and a Marketed Contact Lens</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Vision Care, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johnson &amp; Johnson Vision Care, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare visual acuity and redness of eyes between a prototype
      contact lens and an already marketed contact lens.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2010</start_date>
  <completion_date type="Actual">July 1, 2010</completion_date>
  <primary_completion_date type="Actual">July 1, 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Acuity Monocular</measure>
    <time_frame>after 7 +/- 1 days of lens wear</time_frame>
    <description>Snellen monocular visual acuity measurement was measured in both eyes that wore lenses for one week and came in for the evaluation with an inserted lens.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Acuity Binocular</measure>
    <time_frame>after 7 +/- 1 days of lens wear</time_frame>
    <description>Snellen binocular visual acuity measurement</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subjective Assessment of Lens Comfort Using the Contact Lens User Experience (CLUE)TM Questionnaire.</measure>
    <time_frame>after 7 +/-1 days of lens wear</time_frame>
    <description>The contract Lens Experience (CLUE)TM questionnaire is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subjective Assessment of Quality of Vision Using the Contact Lens User Experience(CLUE)TM Questionnaire.</measure>
    <time_frame>after 7 +/- 1 days of lens wear</time_frame>
    <description>Contact Lens User Experience CLUE)TM questionnaire: A validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Limbal Redness</measure>
    <time_frame>after 7 days of lens wear</time_frame>
    <description>Scale of 0 to 4, where 0=None, 2=Trace, 3=Mild, 4=Moderate, 5=Severe.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bulbar Redness</measure>
    <time_frame>after 7 days of lens wear</time_frame>
    <description>Scale of 0 to 4, where 0=None, 2=Trace, 3=Mild, 4=Moderate, 5=Severe.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective Assessment of Lens Comfort Using the Contact Lens User Experience (CLUE)TM Questionnaire.</measure>
    <time_frame>10 minutes after lens insertion at time of initial lens fitting</time_frame>
    <description>Contact Lens User Experience CLUE)TM questionnaire: A validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">53</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>galyfilcon A prototype/comfilcon A</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The galyfilcon A prototype lenses are worn during first period and comfilcon A lenses worn during second period. Each period consists of daily lens wear for one week.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>comfilcon A/galyfilcon A prototype</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The comfilcon A lenses are worn during first period and galyfilcon A prototype lenses worn during second period. Each period consists of daily lens wear for one week.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>galyfilcon A prototype lens</intervention_name>
    <description>silicone hydrogel contact lens</description>
    <arm_group_label>galyfilcon A prototype/comfilcon A</arm_group_label>
    <arm_group_label>comfilcon A/galyfilcon A prototype</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>comfilcon A</intervention_name>
    <description>silicone hydrogel contact lens</description>
    <arm_group_label>galyfilcon A prototype/comfilcon A</arm_group_label>
    <arm_group_label>comfilcon A/galyfilcon A prototype</arm_group_label>
    <other_name>Biofinity® contact lens</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The subject is a current spherical soft contact lens wearer and willing to wear the
             study lenses on a daily wear basis for the duration of the study.

          -  The subject's optimal vertexed spherical equivalent distance correction must be
             between -1.00 and - 5.00D.

          -  Any cylinder power must be ≤ -0.75D.

          -  The subject must have visual acuity best correctable to 20/25+3 or better for each
             eye.

          -  The subject must read and sign the Statement of Informed Consent.

          -  The subject must appear able and willing to adhere to the instructions set forth in
             the clinical protocol.

        Exclusion Criteria:

          -  Ocular or systemic allergies or disease which might interfere with contact lens wear.

          -  Systemic disease or use of medication which might interfere with contact lens wear.

          -  Clinically significant (grade 3 or 4) corneal edema, corneal vascularization, corneal
             staining, or any other abnormalities of the cornea which would contraindicate contact
             lens wear.

          -  Clinically significant (grade 3 or 4) tarsal abnormalities or bulbar injection which
             might interfere with contact lens wear.

          -  Any ocular infection.

          -  Any corneal distortion resulting from previous hard or rigid gas permeable contact
             lens wear.

          -  Pregnancy or lactation.

          -  Diabetes.

          -  Infectious diseases (e.g. hepatitis, tuberculosis) or an immuno-suppressive disease
             (e.g. HIV).

          -  Habitual contact lens type is toric, multifocal, or is worn as extended wear.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fincastle</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Salem</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 11, 2010</study_first_submitted>
  <study_first_submitted_qc>August 12, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 13, 2010</study_first_posted>
  <results_first_submitted>November 7, 2011</results_first_submitted>
  <results_first_submitted_qc>January 3, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 5, 2014</results_first_posted>
  <last_update_submitted>August 31, 2017</last_update_submitted>
  <last_update_submitted_qc>August 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <recruitment_details>This study was a four (4) site, bilateral crossover study. Data were collected in three (3) visits (initial, 1 wk follow-up, and final visit).</recruitment_details>
      <pre_assignment_details>Fifty-three (53) subjects enrolled, one(1) subject was discontinued and fifty-two (52) completed the study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Galyfilcon A (Test)/Comfilcon A (Control)</title>
          <description>Each subject wore the assigned lens type for 7 +/- 1 days, according to the randomization scheme.</description>
        </group>
        <group group_id="P2">
          <title>Comfilcon A (Control)/Galyfilcon A (Test)</title>
          <description>Each subject wore the assigned lens type for 7 +/- 1 days, according to the randomization scheme.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Period 1 (7 +/- Days)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Period 2 (7 +/- 1 Days)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>All Subjects</title>
          <description>All enrolled subjects at baseline.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="53"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="53"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.00" spread="5.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Visual Acuity Monocular</title>
        <description>Snellen monocular visual acuity measurement was measured in both eyes that wore lenses for one week and came in for the evaluation with an inserted lens.</description>
        <time_frame>after 7 +/- 1 days of lens wear</time_frame>
        <population>Analysis is on those subjects who were enrolled, randomized to a study arm, and completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A Lens (Control)</title>
            <description>All eyes of subjects who wore comfilcon A lenses for 7 +/-1 days to the time of evaluation</description>
          </group>
          <group group_id="O2">
            <title>Galyfilcon A Lens (Test)</title>
            <description>All eyes of subjects who wore galyfilcon A lenses for 7 +/- 1 days to the time of evaluation</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Acuity Monocular</title>
          <description>Snellen monocular visual acuity measurement was measured in both eyes that wore lenses for one week and came in for the evaluation with an inserted lens.</description>
          <population>Analysis is on those subjects who were enrolled, randomized to a study arm, and completed the study.</population>
          <units>eyes</units>
          <param>Number</param>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="52"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="104"/>
                <count group_id="O2" value="104"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>20/15 monocular</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53"/>
                    <measurement group_id="O2" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>20/20 monocular</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49"/>
                    <measurement group_id="O2" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>20/25 monocular</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>20/30 monocular</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Visual Acuity Binocular</title>
        <description>Snellen binocular visual acuity measurement</description>
        <time_frame>after 7 +/- 1 days of lens wear</time_frame>
        <population>Analysis is on those subjects who were enrolled, randomized to a study arm, and completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A Lens (Control)</title>
            <description>All eyes of subjects who wore comfilcon A lenses for 7 +/-1 days to the time of evaluation</description>
          </group>
          <group group_id="O2">
            <title>Galyfilcon A Lens (Test)</title>
            <description>All eyes of subjects who wore galyfilcon A lenses for 7 +/- 1 days to the time of evaluation</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Acuity Binocular</title>
          <description>Snellen binocular visual acuity measurement</description>
          <population>Analysis is on those subjects who were enrolled, randomized to a study arm, and completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="52"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>20/10 binocular</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>20/15 binocular</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>20/20 binocular</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>20/25 binocular</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>20/30 binocular</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Subjective Assessment of Lens Comfort Using the Contact Lens User Experience (CLUE)TM Questionnaire.</title>
        <description>The contract Lens Experience (CLUE)TM questionnaire is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.</description>
        <time_frame>after 7 +/-1 days of lens wear</time_frame>
        <population>Analysis is on those subjects who were enrolled, randomized to a study arm, and completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A Lens (Control)</title>
            <description>All eyes of subjects who wore comfilcon A lenses for 7 +/-1 days to the time of evaluation</description>
          </group>
          <group group_id="O2">
            <title>Galyfilcon A Lens (Test)</title>
            <description>All eyes of subjects who wore galyfilcon A lenses for 7 +/- 1 days to the time of evaluation</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Assessment of Lens Comfort Using the Contact Lens User Experience (CLUE)TM Questionnaire.</title>
          <description>The contract Lens Experience (CLUE)TM questionnaire is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.</description>
          <population>Analysis is on those subjects who were enrolled, randomized to a study arm, and completed the study.</population>
          <units>CLUE score</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.72" spread="4.47"/>
                    <measurement group_id="O2" value="67.06" spread="4.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Limbal Redness</title>
        <description>Scale of 0 to 4, where 0=None, 2=Trace, 3=Mild, 4=Moderate, 5=Severe.</description>
        <time_frame>after 7 days of lens wear</time_frame>
        <population>Analysis is on those subjects who were enrolled, randomized to a study arm, and completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A Lens (Control)</title>
            <description>All eyes of subjects who wore comfilcon A lenses for 7 +/-1 days to the time of evaluation</description>
          </group>
          <group group_id="O2">
            <title>Galyfilcon A Lens (Test)</title>
            <description>All eyes of subjects who wore galyfilcon A lenses for 7 +/- 1 days to the time of evaluation</description>
          </group>
        </group_list>
        <measure>
          <title>Limbal Redness</title>
          <description>Scale of 0 to 4, where 0=None, 2=Trace, 3=Mild, 4=Moderate, 5=Severe.</description>
          <population>Analysis is on those subjects who were enrolled, randomized to a study arm, and completed the study.</population>
          <units>eyes</units>
          <param>Number</param>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="52"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="104"/>
                <count group_id="O2" value="104"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Grade 0 = No redness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37"/>
                    <measurement group_id="O2" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 1 = Trace redness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36"/>
                    <measurement group_id="O2" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 2 = Mild redness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Subjective Assessment of Quality of Vision Using the Contact Lens User Experience(CLUE)TM Questionnaire.</title>
        <description>Contact Lens User Experience CLUE)TM questionnaire: A validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.</description>
        <time_frame>after 7 +/- 1 days of lens wear</time_frame>
        <population>Analysis is on those subjects who were enrolled, randomized to a study arm, and completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A Lens (Control)</title>
            <description>All eyes of subjects who wore comfilcon A lenses for 7 +/-1 days to the time of evaluation</description>
          </group>
          <group group_id="O2">
            <title>Galyfilcon A Lens (Test)</title>
            <description>All eyes of subjects who wore galyfilcon A lenses for 7 +/- 1 days to the time of evaluation</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Assessment of Quality of Vision Using the Contact Lens User Experience(CLUE)TM Questionnaire.</title>
          <description>Contact Lens User Experience CLUE)TM questionnaire: A validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.</description>
          <population>Analysis is on those subjects who were enrolled, randomized to a study arm, and completed the study.</population>
          <units>CLUE score</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.75" spread="2.83"/>
                    <measurement group_id="O2" value="59.98" spread="2.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Bulbar Redness</title>
        <description>Scale of 0 to 4, where 0=None, 2=Trace, 3=Mild, 4=Moderate, 5=Severe.</description>
        <time_frame>after 7 days of lens wear</time_frame>
        <population>Analysis is on those subjects who were enrolled, randomized to a study arm, and completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A Lens (Control)</title>
            <description>All eyes of subjects who wore comfilcon A lenses for 7 +/-1 days to the time of evaluation</description>
          </group>
          <group group_id="O2">
            <title>Galyfilcon A Lens (Test)</title>
            <description>All eyes of subjects who wore galyfilcon A lenses for 7 +/- 1 days to the time of evaluation</description>
          </group>
        </group_list>
        <measure>
          <title>Bulbar Redness</title>
          <description>Scale of 0 to 4, where 0=None, 2=Trace, 3=Mild, 4=Moderate, 5=Severe.</description>
          <population>Analysis is on those subjects who were enrolled, randomized to a study arm, and completed the study.</population>
          <units>eyes</units>
          <param>Number</param>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="52"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="104"/>
                <count group_id="O2" value="104"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Grade 0 = No redness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39"/>
                    <measurement group_id="O2" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 1 = Trace redness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55"/>
                    <measurement group_id="O2" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 2 = Mild redness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subjective Assessment of Lens Comfort Using the Contact Lens User Experience (CLUE)TM Questionnaire.</title>
        <description>Contact Lens User Experience CLUE)TM questionnaire: A validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.</description>
        <time_frame>10 minutes after lens insertion at time of initial lens fitting</time_frame>
        <population>Analysis is on those subjects who were enrolled, randomized to a study arm, and completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A Lens (Control)</title>
            <description>All subjects who wore comfilcon A lenses</description>
          </group>
          <group group_id="O2">
            <title>Galyfilcon A Lens (Test)</title>
            <description>All subjects who wore galyfilcon A lenses</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Assessment of Lens Comfort Using the Contact Lens User Experience (CLUE)TM Questionnaire.</title>
          <description>Contact Lens User Experience CLUE)TM questionnaire: A validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.</description>
          <population>Analysis is on those subjects who were enrolled, randomized to a study arm, and completed the study.</population>
          <units>CLUE score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.32" spread="18.36"/>
                    <measurement group_id="O2" value="82.76" spread="17.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Galyfilcon A Prototype/Comfilcon A</title>
          <description>All enrolled subjects were to wear both lenses through the course of the study.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Publication requires agreement and written consent from the Sponsor.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>John Buch, OD, MS, FAAO</name_or_title>
      <organization>Johnson &amp; Johnson Vision Care</organization>
      <phone>1 904 443-1707</phone>
      <email>jbuch@its.jnj.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

